Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles.

Langert, Kelly A; Goshu, Bruktawit; Stubbs, Evan B

Langert, Kelly A; Goshu, Bruktawit; Stubbs, Evan B.

Affiliation

Langert KA; Research Service, Department of Veterans Affairs, Edward Hines Jr. VA Hospital, Hines, Illinois, USA.
Goshu B; Research Service, Department of Veterans Affairs, Edward Hines Jr. VA Hospital, Hines, Illinois, USA.
Stubbs EB; Research Service, Department of Veterans Affairs, Edward Hines Jr. VA Hospital, Hines, Illinois, USA.

J Neurochem ; 140(2): 334-346, 2017 01.

Article in En | MEDLINE | ID: mdl-27861905

Subject(s)

Guillain-Barre Syndrome/drug therapy; Lovastatin/pharmacology; Nanoparticles/administration & dosage; Neuritis, Autoimmune, Experimental/drug therapy; T-Lymphocytes/drug effects; Animals; Capsules; Disease Models, Animal; Glycols/metabolism; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Sciatic Nerve/drug effects; T-Lymphocytes/immunology

Key words

Guillain-Barré syndrome; lovastatin; nanoparticles; poly(lactic-co-glycolic) acid

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lovastatin / T-Lymphocytes / Guillain-Barre Syndrome / Nanoparticles / Neuritis, Autoimmune, Experimental Limits: Animals Language: En Journal: J Neurochem Year: 2017 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google